NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
12/05/2023
Back to search
Official data from USPTO
A WRIGHT PATH REGULATORY STRATEGY & COMPLIANCE EXCELLENCE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
20
Latest update
12/05/2023
Trademark type
Combined
Nice classes
42
Filing date
09/23/2022
Registration date
12/05/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/05/2023
Last transaction
12/05/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
10/15/2014
First use in commerce
10/15/2014
Drawing code
3
Owner type
03
Owner location
Moon Township, PA, US
Examiner
COLYAR, TRISTAN
Law office
L10
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of "A WRIGHT PATH" in a blue gradient color above the stylized green wording "REGULATORY STRATEGY & COMPLIANCE EXCELLENCE", with a partial underline separating the two lines of text. To the left of the wording is a blue and green gradient color circle with a white curved path running down the middle of the circle. Surrounding the circle is a partial blue and green gradient ring. All of the foregoing is on a white background.
Holders and representatives
Holders
A Wright Path Inc.
Representatives
Steven War WAR IP LAW PLLC
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
Medical and scientific researchconducting clinical trials for others; Conducting research and clinical trials for others relating to medical devices and pharmaceuticals in the field of ophthalmology; Consulting services for others in the field of designplanningimplementation project management of drugs and medical devices for use in connection with orthopedicsdiabetescardiovascular disease; Providing medical and scientific research information; Providing information about medical and scientific research; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Scientific research in the nature of conducting clinical trials for others; Scientific research in the nature of conducting clinical trials for others in the field of drugs and medical devices for use in connection with orthopedicsdiabetescardiovascular disease
Publications
History of USPTO decisions and trademark events.
20 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
12/05/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/19/2023
PUBO
PUBLISHED FOR OPPOSITION
09/19/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/30/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/11/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
08/03/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
08/03/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
08/03/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
08/03/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/25/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/24/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/24/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
07/11/2023
GNRT
NON-FINAL ACTION E-MAILED
07/11/2023
CNRT
NON-FINAL ACTION WRITTEN
07/11/2023
DOCK
ASSIGNED TO EXAMINER
07/07/2023
MDSM
NOTICE OF DESIGN SEARCH CODE E-MAILED
10/12/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/11/2022
NWAP
NEW APPLICATION ENTERED
09/27/2022
Continuous trademark protection
Get notified about every new filing that threatens A WRIGHT PATH REGULATORY STRATEGY & COMPLIANCE EXCELLENCE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.